GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
37,150
+750 (2.06%)
May 13, 2025, 3:30 PM KST
219.98%
Market Cap 1.53T
Revenue (ttm) 62.69B
Net Income (ttm) -87.22B
Shares Out 41.09M
EPS (ttm) -2,202.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 196,625
Average Volume 366,064
Open 36,600
Previous Close 36,400
Day's Range 36,300 - 38,200
52-Week Range 9,060 - 44,550
Beta 0.78
RSI 61.21
Earnings Date May 15, 2025

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1998
Employees 186
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.

Financial Statements

News

There is no news available yet.